Kemnay Advisory Services’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
Kemnay Advisory Services's ADPT Position: Q2 2026 in Review
Kemnay Advisory Services increased its Adaptive Biotechnologies (ADPT) stake by 575% in Q2 2026, buying an estimated $108K and bringing the position to 8,280 shares worth $178K. The position accounts for 0.02% of the portfolio, ranked #53.
Kemnay Advisory Services first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.
- Kemnay Advisory Services held 8,280 shares of Adaptive Biotechnologies worth $178K as of Q2 2026.
- Kemnay Advisory Services bought 7,054 Adaptive Biotechnologies shares in Q2 2026, an estimated $108K.
- Adaptive Biotechnologies made up 0.02% of Kemnay Advisory Services's portfolio in Q2 2026, its #53 holding.
- Kemnay Advisory Services first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
- 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.